Home > Income Statement > BETA DRUGS
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹362 Cr₹29,571,376 Cr₹0.00 Cr₹184 Cr₹116 Cr

What is the latest Revenue of BETA DRUGS ?

The latest Revenue ratio of BETA DRUGS is ₹362 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹362 Cr
Mar2025₹29,571,376 Cr
Mar2024₹0.00 Cr
Mar2023₹184 Cr
Mar2022₹116 Cr

How is Revenue of BETA DRUGS Trending?

Years Revenue % Change
Mar2026 ₹362 Cr
-100.00
Mar2025 ₹29,571,376 Cr
1,478,568,796,850.00
Mar2024 ₹0.00 Cr
-100.00
Mar2023 ₹184 Cr
58.31
Mar2022 ₹116 Cr -

Compare Revenue of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹1,837.5 Cr -8.9% -16% 6.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹452,299.0 Cr 1% 7.5% 7.9% Stock Analytics
DIVIS LABORATORIES ₹297,325.0 Cr 0.8% 22.8% 71.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹178,727.0 Cr 0.2% 1.9% 20.9% Stock Analytics
DR REDDYS LABORATORIES ₹116,145.0 Cr 0.8% 12.2% 12.3% Stock Analytics
CIPLA ₹114,312.0 Cr 1.5% 6.4% -7.8% Stock Analytics


BETA DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

-8.9%

-16%

6.7%

SENSEX

2.9%

13.9%

-0.8%


You may also like the below Video Courses